Coupling of dopamine D1 recognition sites with adenylate cyclase in nuclei accumbens and caudatus of schizophrenics.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Science

• Publication date

  1983-09-23

• Fields of study

  Medicine, Chemistry, Psychology

• Identifiers
  DOI 10.1126/SCIENCE.6310753PMID 6310753
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Agonist-induced subsensitivity of adenylate cyclase coupled with a dopamine receptor in slices from rat corpus striatum.

  1982cited by this paper
• D-2 dopamine receptor-mediated inhibition of adenylate cyclase activity in the intermediate lobe of the rat pituitary gland requires guanosine 5'-triphosphate.

  1982cited by this paper
• Perivascular infiltrates of leukocytes in brains of scrapie-infected mice

  1981cited by this paper
• Dopamine receptors and schizophrenia: drug effect or illness?

  1980cited by this paper
• The role of hormone receptors and GTP-regulatory proteins in membrane transduction

  1980cited by this paper
• The role of the guanine nucleotide exchange reaction in the regulation of the beta-adrenergic receptor and in the actions of catecholamines and cholera toxin on adenylate cyclase in turkey erythrocyte membranes.

  1980cited by this paper
• Elevation of brain neuroleptic/dopamine receptors in schizophrenia.

  1980cited by this paper
• Prostacyclin therapy of thrombotic thrombocytopenic purpura.

  1980cited by this paper
• Brain dopamine receptors.

  1980cited by this paper
• Determination of the turn-off reaction for the hormone-activated adenylate cyclase.

  1979cited by this paper
• Monoamine Mechanisms in Chronic Schizophrenia: Post-Mortem Neurochemical Findings

  1979cited by this paper
• Dopaminergic mechanisms in schizophrenia: the antipsychotic effect and the disease process.

  1978cited by this paper
• Effects of neuroleptics on 3H-haloperidol and 3H-cis(Z)-flupenthixol binding and on adenylate cyclase activity in vitro.

  1978cited by this paper
• Increased dopamine-receptor sensitivity in schizophrenia.

  1978cited by this paper
• Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain.

  1977cited by this paper
• Mechanism of adenylate cyclase activation by cholera toxin: inhibition of GTP hydrolysis at the regulatory site.

  1977cited by this paper
• Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.

  1976cited by this paper
• Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs

  1976cited by this paper
• Biochemical aspects of schizophrenia.

  1975cited by this paper
• Dopamine-sensitive adenylyl cyclase in human caudate nucleus. A study in control subjects and schizophrenic patients.

  1975cited by this paper
• Clinical criteria for psychiatric diagnosis and DSM-III.

  1975cited by this paper
• A two factor theory of schizophrenia.

  1974cited by this paper
• Drugs, neurotransmitters, and schizophrenia.

  1974cited by this paper
• Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor".

  1972cited by this paper
• Biochemical theories of schizophrenia. I.

  1959cited by this paper

• The alternations of nucleus accumbent in schizophrenia patients with auditory verbal hallucinations during low-frequency rTMS treatment

  2022cites this paper
• G protein gene variants in schizophrenia

  2020cites this paper
• Dopamine receptors mediate strategy abandoning via modulation of a specific prelimbic cortex–nucleus accumbens pathway in mice

  2018cites this paper
• A Role for Phosphodiesterase 11A (PDE11A) in the Formation of Social Memories and the Stabilization of Mood.

  2017cites this paper
• PDE11A regulates social behaviors and is a key mechanism by which social experience sculpts the brain.

  2016cites this paper
• Does phosphodiesterase 11A (PDE11A) hold promise as a future therapeutic target?

  2014cites this paper
• ouse behavioral endophenotypes for schizophrenia

  2010cites this paper
• Pharmacology of signaling induced by dopamine D(1)-like receptor activation.

  2010cites this paper
• Genetic dissection of neural circuits and behavior in Mus musculus.

  2009cites this paper
• Developmental etiology for neuroanatomical and cognitive deficits in mice overexpressing Gαs, a G-protein subunit genetically linked to schizophrenia

  2009cites this paper
• Long-Term Upregulation of Protein Kinase A and Adenylate Cyclase Levels in Human Smokers

  2007cites this paper
• Constitutive Activation of Gαs within Forebrain Neurons Causes Deficits in Sensorimotor Gating Because of PKA-Dependent Decreases in cAMP

  2007cites this paper
• Low baseline serotonin-2A receptors predict clinical response to olanzapine in first-episode schizophrenia patients.

  2007cites this paper
• G-proteins (Gi, Go) in the basal ganglia of control and schizophrenic brain

  2005cites this paper
• The dopamine hypothesis of schizophrenia: limbic interactions with serotonin and norepinephrine

  2005cites this paper
• D 2 Dopamine Receptors Modulate G-Subunit Coupling of the CB 1 Cannabinoid Receptor

  2004cites this paper
• The negative symptoms of schizophrenia and the monoamine oxidase inhibitors

  2004cites this paper
• Very mild stress of pregnant rats reduces volume and cell number in nucleus accumbens of adult offspring: some parallels to schizophrenia.

  2004cites this paper
• D2 Dopamine Receptors Modulate Gα-Subunit Coupling of the CB1 Cannabinoid Receptor

  2004cites this paper
• Biochemical and behavioural properties of clozapine

  2004cites this paper
• Physiology, Pharmacology and Pathophysiology of the D1-like Family of Dopamine Receptors in the Central Nervous System

  2003cites this paper
• Heterologous sensitization of recombinant adenylate cyclases by activation of D(2) dopamine receptors.

  2001cites this paper
• Aberrant behavioral effects of a dopamine D1 receptor antagonist and agonist in monkeys: evidence of uncharted dopamine D1 receptor actions.

  2001cites this paper
• Differential Effects of the Antipsychotics Haloperidol and Clozapine on G Protein Measures in Mononuclear Leukocytes of Patients with Schizophrenia

  2001cites this paper
• Dopamine D1-stimulated adenylyl cyclase activity in cerebral cortex of autopsied human brain.

  2001cites this paper
• Elevated dopamine receptor-coupled G(s) protein measures in mononuclear leukocytes of patients with schizophrenia.

  2001cites this paper
• D1 Dopamine Receptors, Schizophrenia, and Antipsychotic Medications

  2000cites this paper
• Modulation of Cellular Signaling Pathways by Antipsychotic Drugs

  2000cites this paper
• Differential effects of treatment with typical and atypical antipsychotic drugs on adenylyl cyclase and G proteins.

  1999cites this paper
• Short- and long-term heterologous sensitization of adenylate cyclase by D4 dopamine receptors

  1999influential citation
• Isotype-specific G protein abnormalities in the left superior temporal cortex and limbic structures of patients with chronic schizophrenia.

  1998cites this paper
• Dopamine Receptors and Clinical Medicine

  1997cites this paper
• A Novel Regulation of Expression of the α‐Subunit of the G Stimulatory Protein by Dopamine via D1 Dopamine Receptors

  1997cites this paper
• Increased cyclic AMP response to forskolin in Epstein-Barr virus-transformed human B-lymphocytes derived from schizophrenics

  1997influential citation
• G Proteins in the Etiology and Treatment of Mental Disorders

  1997cites this paper
• The neuropathology of schizophrenia.

  1996cites this paper
• Neither protein kinase C nor adenylate cyclase are altered in the striatum from subjects with schizophrenia.

  1996cites this paper
• "Full" dopamine D1 agonists in human caudate: biochemical properties and therapeutic implications.

  1995cites this paper
• Distribution and development of G alpha i-2 mRNA in the rat cerebral cortex investigated with in situ hybridization and RNAse protection assay.

  1995cites this paper
• PET in the Development of Dopamine D1 Antagonists as New Potential Antipsychotic Drugs

  1995cites this paper
• Dopamine D4 receptors and effects of guanine nucleotides on [3H]raclopride binding in postmortem caudate nucleus of subjects with schizophrenia or major depression.

  1995cites this paper
• Neurotransmitter systems in schizophrenia.

  1995cites this paper
• [Current status of biochemical hypotheses in the pathogenesis of schizophrenia].

  1994cites this paper
• THE PHARMACOLOGY OF CLOZAPINE-LIKE, ATYPICAL ANTIPSYCHOTICS

  1993cites this paper
• Deafferentation induces early and delayed differential changes in the pattern of expression of the various guanine nucleotide binding protein mRNAs in rat striatum.

  1993cites this paper
• High- and low-affinity states of dopamine D1 receptors in schizophrenia.

  1993cites this paper
• Schizophrenia: Dopamine D1 Receptor Sequence Is Normal, But Has DNA Polymorphisms

  1993cites this paper
• Increase in [3H]cAMP binding sites and decrease in Giα and Goα immunoreactivities in left temporal cortices from patients with schizophrenia

  1993cites this paper
• Regional distribution of guanine nucleotide binding proteins (Gs and Gi α) in human brain: correlation with adenylyl cyclase activity

  1993cites this paper
• CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia

  1993cites this paper
• Regional distribution of guanine nucleotide binding proteins (Gs and Gi alpha) in human brain: correlation with adenylyl cyclase activity.

  1993cites this paper
• Increase in [3H]cAMP binding sites and decrease in Gi alpha and Go alpha immunoreactivities in left temporal cortices from patients with schizophrenia.

  1993cites this paper
• G proteins: implications for psychiatry.

  1992cites this paper
• Adenylyl Cyclase Activity in Postmortem Human Brain: Evidence of Altered G Protein Mediation in Alzheimer's Disease

  1992cites this paper
• ENDOTHELIUM‐DEPENDENT AND‐INDEPENDENT RELAXATION BY DOPAMINE IN THE RABBIT PULMONARY ARTERY

  1992cites this paper
• The role of adenylate cyclase in neuropsychiatric disease.

  1992cites this paper
• Schizophrenia and the D1 receptor: Focus on negative symptoms

  1992cites this paper
• Biochemistry of schizophrenia

  1992cites this paper
• NNC-112, NNC-687 and NNC-756, new selective and highly potent dopamine D1 receptor antagonists.

  1992cites this paper
• Dopamine and norepinephrine activity in schizophrenia. An integrative perspective.

  1991cites this paper
• G(olf) in the basal ganglia.

  1991cites this paper
• Positron emission tomography and magnetic resonance imaging: a review and a local circuit neurons hypo(dys)function hypothesis of schizophrenia.

  1991cites this paper
• Maturational and aging effects on guanine nucleotide binding protein immunoreactivity in human brain.

  1991cites this paper
• The biochemical basis of relapse and drug response in schizophrenia: review and hypothesis

  1991cites this paper
• [Brain dopamine receptors. Interactions between D1 and D2 receptors, and dopamine mediated behaviour].

  1991cites this paper
• Characterization and regional distribution of adenylyl cyclase activity from human brain.

  1991cites this paper
• The biochemical basis of relapse and drug response in schizophrenia: review and hypothesis.

  1991cites this paper
• Are Biochemical Markers for Treatment‐Resistant Schizophrenia State Dependent or Traits?

  1990cites this paper
• Cyclic AMP second messenger signal generation in EBV-transformed lymphoblastoid cells from schizophrenic patients.

  1990cites this paper
• Receptor-effector coupling by G-proteins: implications for neuronal plasticity.

  1990cites this paper
• Dopamine D-1 and D-2 receptors in relation to reward and performance: a case for the D-1 receptor as a primary site of therapeutic action of neuroleptic drugs.

  1990cites this paper
• Beyond the Dopamine Hypothesis

  1989cites this paper
• Modulation of second messenger function in rat brain by in vivo alteration of receptor sensitivity: relevance to the mechanism of action of electroconvulsive therapy and antidepressants.

  1989cites this paper
• Clozapine: New research on efficacy and mechanism of action

  1989cites this paper
• Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system

  1989cites this paper
• Methods for Determining the Effects of Drugs on Learning

  1989cites this paper
• Enhancement of dopamine actions on rat nucleus accumbens neurones in vitro after methamphetamine pre‐treatment.

  1989cites this paper
• Are antagonists of dopamine D1 receptors drugs that attenuate both positive and negative symptoms of schizophrenia? A pilot study in Java monkeys.

  1989cites this paper
• Dopamine Receptor Changes During Chronic Drug Administration

  1989cites this paper
• Agonist Binding to Striatal Dopamine Receptors in Aging The Ternary Complex of Receptor and Guanine Nucleotide Binding Regulatory Protein

  1988cites this paper
• Post-mortem neurochemistry of schizophrenia

  1988cites this paper
• Therapeutic potential of selective D-1 dopamine receptor agonists and antagonists in psychiatry and neurology.

  1988cites this paper
• The current status of the dopamine hypothesis of schizophrenia.

  1988cites this paper
• Dopamine neurochemical profile of atypical antipsychotics resembles that of D-1 antagonists

  1988cites this paper
• Chronic treatment with dopamine receptor antagonists: behavioral and pharmacologic effects on D1 and D2 dopamine receptors

  1988influential citation
• The neuropathology of schizophrenia.

  1988cites this paper
• Organization of dopamine D1 and D2 receptors in human striatum: Receptor autoradiographic studies in Huntington's disease and schizophrenia

  1988cites this paper
• Status of the dopaminergic system in post-mortem brain in schizophrenia.

  1988cites this paper
• Dopamine Receptor Subtypes: Differential Regulatory Characteristics and Levels in Schizophrenia

  1988cites this paper
• Schizophrénie: l'hypothèse dopaminergique à l'épreuve de la génétique moléculaire. I

  1988cites this paper
• The attitudes of psychiatrists toward etiological theories of schizophrenia: 1975-1985.

  1987cites this paper
• Post-synaptic changes and increased dopamine receptor sensitivity in hypothyroid rats.

  1987cites this paper
• The D-1 Dopamine Receptor and the Search for its Functional Role: From Neurochemistry to Behaviour

  1987cites this paper
• Dopamine receptor subtype imbalance in schizophrenia.

  1987cites this paper
• Biological studies in schizophrenia.

  1987cites this paper
• Pharmacological and biochemical characterization of the D-1 dopamine receptor mediating acetylcholine release in rabbit retina.

  1987cites this paper
• Differential up‐regulation of D‐1 and D‐2 dopamine receptor function in mesostriatal areas but not in cortical‐limbic brain regions of rats chronically treated with (—)sulpiride and SCH 23390

  1987cites this paper
• Dopamine receptors and the dopamine hypothesis of schizophrenia

  1987cites this paper
• Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases.

  1987cites this paper
• Review: D1 dopamine receptor—the search for a function: A critical evaluation of the D1/D2 dopamine receptor classification and its functional implications

  1987cites this paper